PROSHARES TR - SHRT HGH YIELD (SJB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / SHRT HGH YIELD
Symbol
SJB
Price per share
$15.26
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,167,560
Total reported value
$33,325,432
% of total 13F portfolios
0%
Share change
-1,021,367
Value change
-$16,082,006
Number of holders
15
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 15 institutional investors reported holding 2,167,560 shares of PROSHARES TR - SHRT HGH YIELD (SJB).

Institutional Holders of PROSHARES TR - SHRT HGH YIELD (SJB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 260,865 $3,980,800 -$947,216 $15.26 1
2025 Q3 2,167,560 $33,325,432 -$16,082,006 $15.38 15
2025 Q2 3,178,513 $49,989,581 +$17,166,979 $15.60 24
2025 Q1 2,063,795 $33,501,872 +$20,235,429 $16.12 18
2024 Q4 822,219 $13,278,003 -$31,197,977 $16.15 18
2024 Q3 2,741,284 $44,519,103 +$1,285,374 $16.19 31
2024 Q2 2,624,212 $44,468,228 -$14,929,004 $16.94 27
2024 Q1 3,485,717 $59,605,663 -$11,694,144 $17.10 31
2023 Q4 4,145,809 $71,404,697 -$27,171,243 $17.24 39
2023 Q3 5,760,936 $106,287,127 +$18,032,284 $18.45 40
2023 Q2 4,785,378 $87,686,090 -$53,638,303 $18.32 42
2023 Q1 7,712,649 $141,695,108 -$7,349,656 $18.36 47
2022 Q4 8,052,347 $152,999,078 +$22,665,531 $19.00 62
2022 Q3 6,786,325 $135,676,434 -$8,012,760 $20.01 54
2022 Q2 11,295,723 $223,152,036 +$176,394,176 $19.76 56
2022 Q1 2,219,222 $40,241,533 +$34,286,168 $18.10 31
2021 Q4 281,415 $4,911,000 -$1,627,079 $17.42 15
2021 Q3 346,793 $6,145,000 -$985,188 $17.72 14
2021 Q2 401,076 $7,192,000 -$4,490,497 $17.94 15
2021 Q1 670,089 $12,358,000 +$1,357,747 $18.45 21
2020 Q4 587,626 $10,969,000 -$8,093,667 $18.67 17
2020 Q3 1,009,134 $20,111,000 -$4,948,275 $19.93 19
2020 Q2 1,249,164 $26,117,000 -$37,365,265 $20.91 25
2020 Q1 2,647,825 $60,634,000 +$23,222,688 $22.90 27
2019 Q4 1,474,381 $30,363,000 +$442,848 $20.58 19
2019 Q3 1,436,991 $30,388,000 -$4,400,877 $21.13 19
2019 Q2 1,644,187 $35,246,125 +$6,608,180 $21.42 19
2019 Q1 1,334,462 $29,202,943 -$5,454,052 $21.88 23
2018 Q4 1,504,974 $35,425,128 -$13,115,056 $23.52 27
2018 Q3 1,796,084 $40,580,262 -$12,196,611 $22.52 20
2018 Q2 2,343,628 $54,351,595 -$20,459,813 $23.19 25
2018 Q1 3,201,751 $74,987,690 +$53,034,208 $23.38 24
2017 Q4 939,373 $21,717,560 -$6,355,780 $23.12 21
2017 Q3 1,244,753 $28,776,560 +$9,390,609 $23.12 16
2017 Q2 1,375,000 $32,355,059 -$8,397,601 $23.53 23
2017 Q1 1,696,612 $40,786,808 -$3,972,628 $24.04 20
2016 Q4 1,855,305 $45,710,000 -$45,106,202 $24.64 24
2016 Q3 3,685,936 $92,203,000 -$5,827,442 $25.01 25
2016 Q2 3,835,777 $100,621,000 +$25,364,678 $26.23 26
2016 Q1 2,715,216 $75,346,000 +$14,005,617 $27.73 24
2015 Q4 2,170,246 $62,179,000 +$5,799,819 $28.65 25
2015 Q3 1,967,200 $56,162,000 +$47,570,529 $28.56 16
2015 Q2 304,995 $8,330,000 -$715,058 $27.33 14
2015 Q1 331,681 $9,032,765 +$602,833 $27.24 13
2014 Q4 309,488 $8,664,712 -$2,052,594 $28.00 12
2014 Q3 382,603 $10,714,000 +$945,634 $28.00 13
2014 Q2 349,278 $9,635,000 -$427,410 $27.59 11
2014 Q1 363,744 $10,323,000 -$2,698,350 $28.39 14